{"organizations": [], "uuid": "ff08c3de5df5400234c6d7637760e4b072265fc7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2016/05/31/103677956-DSC00852.600x400.JPG", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/01/03/spark-gene-therapy-drug-priced-less-than-expected-at-850000.html", "country": "US", "domain_rank": 767, "title": "Spark gene therapy drug priced less than expected at $850,000", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T15:34:00.000+02:00", "replies_count": 0, "uuid": "ff08c3de5df5400234c6d7637760e4b072265fc7"}, "author": "", "url": "https://www.cnbc.com/video/2018/01/03/spark-gene-therapy-drug-priced-less-than-expected-at-850000.html", "ord_in_thread": 0, "title": "Spark gene therapy drug priced less than expected at $850,000", "locations": [], "entities": {"persons": [{"name": "meg tirrell", "sentiment": "negative"}, {"name": "luxturna", "sentiment": "none"}], "locations": [], "organizations": [{"name": "cnbc", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Spark gene therapy drug priced less than expected at $850,000 2 Hours Ago CNBC's Meg Tirrell reports Spark Therapeutics' Luxturna, which treats an inherited form of vision loss, will come to market under $1 million.", "external_links": [], "published": "2018-01-03T15:34:00.000+02:00", "crawled": "2018-01-03T18:12:09.028+02:00", "highlightTitle": ""}